In our study, we found that overexpression of stroma galectin-3 would predict worse DMFS in univariable analysis; however, overexpression of tumor galectin-3 had no significant effect on the survival outcomes in the patients with lung adenocarcinoma after radiation therapy. This evidence concerns the gene LGALS3 and lung adenocarcinoma.